IBR launches anti-ageing ingredient that targets rosacea

By Katie Nichol

- Last updated on GMT

Related tags: In vitro

Natural active ingredients company IBR has launched a new ingredient with anti-ageing and calming properties.

The Israel-based company claims that IBR-CalmDeAge is able to slow down cell proliferation as well as prevent oxidative damage.

Derived from palm date seed, the water-soluble extract also provides relief from symptoms of rosacea, (a chronic condition characterized by facial erythema (redness)) according to IBR.

Clinical trials

The company conducted an in-vivo​ study on the ingredient to demonstrate its efficacy as an anti-wrinkle and anti-rosacea ingredient.

Over a 28-day period, 12 female volunteers between the ages of 50-69 applied a formulation containing IBR-CalmDeAge at 5 per cent to their skin twice a day.

Results showed that use of cream containing the ingredient led to a decrease in both the number and length of wrinkles after 28 days, with average wrinkle length decreasing by 30 per cent.

Furthermore, after 28 days of using the IBR-CalmDeAge-containing formula, a 27 per cent decrease in both the total surface and the ratio of rosacea was recorded, the company said.

In vitro ​tests carried out on the ingredient demonstrated its antioxidant activity using a Trolox equivalent, and indicated its ability to slow down cell proliferation (IBR-CalmDeAge concentration levels of 0.12 per cent led to a 13 per cent decrease on keratinocytes proliferation).

Suitable for a variety of personal care applications

According to the company, the ingredient is suitable for use in anti-ageing skin care applications, skin care formulations designed for rosacea sufferers, and sun and hair care products.

IBR will be showcasing IBR-CalmDeAge at the forthcoming in-cosmetics tradeshow in Paris on 13-15 April.

Related topics: Formulation & Science

Related news

Show more

Follow us

Featured Events

View more

Products

View more

Webinars